.05 semaglutide Type 2 diabetes: New Ozempic pill now available in the U.S Semaglutide phase 3 SUSTAIN trials

A review of evidence and relevance

Don Colbert, M.D

One of the highlights of the webinar was hearing the patient perspective from my friend and colleague, Patty Nece As always, Patty eloquently articulated WHY this matters and reminded us that improving access requires partnership among patients, healthcare professionals, pharmacists, advocates, and policymakers

For example, oxidative stress-induced microRNA-9/9* has been implicated in the MELAS phenotype, while downregulation of microRNA-181a/b, which promotes MQC through the activation of mitochondrial biogenesis and mitophagy, has shown protective effects on RGCs in an LHON mouse model